Trials / Unknown
UnknownNCT02895646
Genomic Study of Genetic Polymorphisms Involved in Immediate Allergic Reactions to Beta-lactam Antibiotics
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,356 (actual)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Beta-lactam antibiotics include penicillin and cephalosporins and are among the most prescribed antibiotics. This category of drugs is the most involved in immediate allergic manifestations with 2% reactions in treated subjects and a fatal outcome in 1/50000 treatments. Reactions are IgE-mediated and have a considerable but unknown genetic origin, revealed by studies in groups of different ethnical origins in the same geographical region. There are also some families with a high frequency of allergic reactions without identified Mendelian inheritance. The purpose of this study is to identify predictive risk factors associated to immediate allergic reactions against beta-lactam antibiotics with a pangenomic approach. A secondary purpose is to identify rare predictive factors with homozygosity mapping and exome sequencing in various families with high risk of allergy to beta-lactam antibiotics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Collection of blood sample |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2016-09-12
- Last updated
- 2017-02-03
Source: ClinicalTrials.gov record NCT02895646. Inclusion in this directory is not an endorsement.